methylprednisolone and Mast Cell Activation Disease

methylprednisolone has been researched along with Mast Cell Activation Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amano, H; Igarashi, Y; Kanbe, N; Kurimoto, F; Kurosawa, M; Miyachi, Y; Nagata, H; Yamashita, T1
Hanna, P; López, A; McConkey, S; Spracklin, D1

Other Studies

2 other study(ies) available for methylprednisolone and Mast Cell Activation Disease

ArticleYear
Response to cyclosporin and low-dose methylprednisolone in aggressive systemic mastocytosis.
    The Journal of allergy and clinical immunology, 1999, Volume: 103, Issue:5 Pt 2

    Topics: Bone Marrow Cells; Chymases; Cyclosporine; Dose-Response Relationship, Drug; Hematologic Tests; Histamine Release; Humans; Inflammation Mediators; Karyotyping; Male; Mast Cells; Mastocytosis; Methylprednisolone; Middle Aged; Serine Endopeptidases; Tryptases

1999
Cutaneous mucinosis and mastocytosis in a shar-pei.
    The Canadian veterinary journal = La revue veterinaire canadienne, 1999, Volume: 40, Issue:12

    Topics: Animals; Azathioprine; Dog Diseases; Dogs; Euthanasia; Fatal Outcome; Female; Immunosuppressive Agents; Mastocytosis; Methylprednisolone; Methylprednisolone Acetate; Mucinoses

1999